Pluri Inc. (PLUR) stock
PLURNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
$0.98−0.06 (-5.77%)
Close on Nov 17, 2026Market cap $12.10MP/E –Yield –
Pluri price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Pluri's price to sales ratio was 12.8× on Nov 11, 2026, against 23.2× a year earlier. Over the last 5 years it ranged from 10.7× to 236.1×, with a median of 45.1×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 12.8× | −5.6 |
| 2025 | Dec 31, 2025 | 18.4× | −21.0 |
| 2024 | Dec 31, 2024 | 39.4× | −55.2 |
| 2023 | Dec 29, 2023 | 94.6× | −2.7 |
| 2022 | Oct 31, 2022 | 97.2× | +53.5 |
| 2016 | Oct 31, 2016 | 43.7× | −192.4 |
| 2015 | Dec 31, 2015 | 236.1× | −222.9 |
| 2014 | Dec 31, 2014 | 459.0× | +95.1 |
| 2013 | Dec 31, 2013 | 363.9× | +16.8 |
| 2012 | Dec 31, 2012 | 347.1× | – |
See a number that looks wrong?